Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists.
Kathryn F MilehamCaroline SchenkelSuanna S BruinoogeJanet Freeman-DailyUpal Basu RoyAmy MooreRobert A SmithElizabeth Garrett-MayerLauren RosenthalEdward B GaronBruce E JohnsonRaymond U OsarogiagbonShadia JalalShamsuddin ViraniMary Weber RedmanGerard A SilvestriPublished in: Cancer medicine (2021)
Respondents reported high biomarker testing rates in patients with NSCLC. Treatment decisions were impacted by test turnaround time and associated with practice setting and physician specialization and experience.